Dr. Iulia-Elisabeta Szabo

Competente in:

• Ecografie muschi si articulatii

• 2024: Diploma Doctor in Stiinte Medicale - domeniul Medicina

Atestate, cursrui si workshop-uri:

• 2026:
  • Managementul Interventional al Durerii - workshop hands-on cu scanari ecografice si proceduri ghidate fluoroscopic, ARAI
• 2025:
  • Workshop hands-on de Management Interventional al Durerii, cu scanari ecografice si proceduri ghidate fluoroscopic, ARAI
  • Tehnici avansate de Terapie Interventionala a Durerii - curs pre-congres, al doilea Congres National de Terapie Interventionala a Durerii, ARAI
  • Tehnici Avansate de Terapie Interventionala a Durerii - workshop cu sesiuni hands-on ghidate ecografic si fluoroscopic, ARAI
• 2023:
  • EULAR Scientific Training Grant for Young Fellow, European Alliance of Associations for Rheumatology
  • Atestat de studii complementare in reumatologie pediatrica, Ministerul Sanatatii
• 2022:
  • Atestat de studii complementare in ecografia aparatului locomotor, Ministerul Sanatatii
  • Atestat de studii complementare in ultrasonografie generala, Ministerul Sanatatii
  • Curs postuniversitar - Ecografia musculoscheletala - Modul II (Advanced), Universitatea de Medicina si Farmacie "Iuliu Hatieganu"
• 2021:
  • Curs postuniversitar - Ultrasonografia generala - Modul II, Universitatea de Medicina si Farmacie "Iuliu Hatieganu"
  • Curs postuniversitar - Ecografia musculoscheletala - Modul I (Basic), Universitatea de Medicina si Farmacie "Iuliu Hatieganu"
  • Curs postuniversitar - Ultrasonografia generala - Modul I, Universitatea de Medicina si Farmacie "Iuliu Hatieganu"
  • EULAR European Certificate of Rheumatology - Live Examination, European Alliance of Associations for Rheumatology (EULAR)
  • Certificat de medic specialist in specialitatea reumatologie, Ministerul Sanatatii
• 2020:
  • EULAR Course on Rheumatic Diseases, European Alliance of Associations of Rheumatology
• 2017:
  • EUSTAR Course, EULAR Scleroderma Trials and Research Group (EUSTAR) / World Scleroderma Foundation

• Novel Concepts in Systemic Sclerosis Pathogenesis: Role for miRNAs - Szabo I, Muntean L, Crisan T, Rednic V, Sirbe C, Rednic S; Biomedicines, nr. 6, 2021, ISI.
• Enhanced Innate and Acquired Immune Responses in Systemic Sclerosis Primary Peripheral Blood Mononuclear Cells (PBMCs) - Szabo I, Badii M, Gaal IO, Szabo R, Popp RA, Joosten LAB, Crisan TO, Rednic S; International Journal of Molecular Sciences, nr. 8, ISSN 1422-0067, 2023, ISI.
• Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis - Szabo I, Badii M, Gaal IO, Szabo R, Sirbe C, Humita O, Joosten LAB, Crisan TO, Rednic S; International Journal of Molecular Sciences, nr. 9, ISSN 1422-0067, 2023, ISI.
• Pathogenesis of Autoimmune Hepatitis - Cellular and Molecular Mechanisms - Claudia Sirbe, Gelu Simu, Iulia Szabo, Alina Grama, Tudor Lucian Pop; International Journal of Molecular Sciences, 17 decembrie 2021, vol. 22, nr. 24, articol 13578.
• Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes - Gemma Lepri, Paolo Airo, Oliver Distler, Kristofer Andreasson, Yolanda Braun-Moscovici, Eric Hachulla, Alexandra Balbir-Gurman, Ellen De Langhe, Simona Rednic, Francesca Ingegnoli, Edoardo Rosato, Laura Groseanu, Ruxandra Ionescu, Silvia Bellando-Randone, Liudmila Garzanova, Lorenzo Beretta, Chiara Bellocchi, Sergey Moiseev, Pavel Novikov, Iulia Szabo, Dorota Krasowska, Veronica Codullo, Ulrich A Walker, Chrysoula Manolaraki, Serena Guiducci, Marie-Elise Truchetet, Florenzo Iannone, Lorenzo Tofani, Cosimo Bruni, Vanessa Smith, Giovanna Cuomo, Martin Krusche, Marco Matucci-Cerinic, Yannick Allanore; Journal of Scleroderma and Related Disorders, octombrie 2023, vol. 8, nr. 3, pp. 210-220.
• Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort - Carina Mihai, Oliver Distler, Ana Maria Gheorghiu, Paul I Constantin, Rucsandra Dobrota, Suzana Jordan, Vanessa Smith, Eric Hachulla, Jorg Henes, Elise Siegert, Serena Vettori, Ulf Muller-Ladner, Marco Matucci Cerinic, Yannick Allanore si EUSTAR collaborators; Rheumatology (Oxford), 1 august 2020, vol. 59, nr. 8, pp. 2016-2023.
• Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19 - Robert Szabo, Cristina Petrisor, Constantin Bodolea, Vlad Dobre, Sebastian Tranca, Simona Clichici, Iulia Szabo, Razvan Marian Melinte, Teodora Mocan; Pharmaceutics, 14 februarie 2023, vol. 15, nr. 2, articol 646.
• The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133) - Petelytska L, Tofani L, Velauthapillai A, Dobrota R, Becker MO, Mihai C, Muraru S, Elhai M, Jordan S, Hachulla E, Muller-Ladner U, Siegert E, Allanore Y, Riemekasten G, Bergmann C, Becvar R, Solanki K, Anic B, Szabo I, Stamenkovic B, Distler J, Carreira PE, Cuomo G, Castellvi I, Balbir-Gurman A, Airo P, Litinsky I, Saketkoo LA, Bertaccini B, Vonk MC, de Vries-Bouwstra J, Hoffmann-Vold AM, Matucci-Cerinic M, Distler O, Bruni C si EUSTAR collaborators; Annals of the Rheumatic Diseases, aprilie 2026, vol. 85, nr. 4, pp. 669-679.
• Unmet needs and challenges in the diagnosis and management of antiphospholipid syndrome: a qualitative stakeholder study within the ReCONNET framework - Sciascia S, Aguillera S, Marinello D, Tektonidou MG, Cervera R, Tincani A, Talarico R, Mosca M si ERN-ReCONNET APS WG; Lupus Science & Medicine, 9 octombrie 2025, vol. 12, nr. 2, articol e001703.